CA
NZ
UK
AU
IND
US
NEXGEL (NASDAQ:NXGL) fell about 19% to USD 4.07 in early trading on Monday, October 26, 2026, from a prior close near USD 5.03. The company has not issued a release explaining the move, and the decline is not a split artefact, because the 1-for-20 …
Tantech Holdings (NASDAQ:TANH), a China-based maker of bamboo charcoal products, home furnishings and building materials, traded about 18.18% lower, near USD 14.49, in early trading on Monday, October 26, 2026. The company has not issued a release explaining the move, and its latest announcements …
ArriVent BioPharma (NASDAQ:AVBP), a clinical-stage oncology company, traded about 18.07% lower, near USD 17.20, in early trading on Monday, October 26, 2026. The company has not attributed the move to a specific event, but it presented initial Phase 1 data for ARR-217 at the …
CDT Equity (NASDAQ:CDT), which acquires and repositions licensed clinical compounds, traded about 17.31% lower, near USD 0.1075 on an intraday basis, in early trading on Monday, October 26, 2026. The company has not issued a release explaining the move. Its most recent announcement, on …
Vinci Compass Investments (NASDAQ:VINP), which manages private equity, credit, real estate and other funds in Brazil and Latin America, traded at USD 9.55 in early trading on Monday, October 26, 2026. That is a fall of 16.88%, and the implied Friday, October 23 close …
Patria Investments (NASDAQ:PAX), which manages private equity, infrastructure, credit and real estate funds across Latin America, traded at USD 9.78 in early trading on Monday, October 26, 2026. That is a fall of 16.70%, and the implied Friday, October 23 close is about USD …
NIP Group (NASDAQ:NIPG), an esports and digital entertainment company that has moved into bitcoin mining, traded about 16.67% lower, near USD 4.00 intraday, in early trading on Monday, October 26, 2026. The company has not issued a release explaining the move, but its recent …
GRI Bio (NASDAQ:GRI), a clinical-stage biotechnology company that completed a reverse merger with Vallon Pharmaceuticals in 2023, traded about 16.48% lower, near USD 0.7851 intraday, in early trading on Monday, October 26, 2026. The company has not issued a release explaining the move. The …
Lakewood-Amedex Biotherapeutics (NASDAQ:LABT), a clinical-stage developer of Bisphosphocin antimicrobial compounds, traded at USD 0.2601 in early trading on Monday, October 26, 2026, down 16.10% from a Friday close of about USD 0.31. The company has not issued a release explaining the move. The most …
Cumberland Pharmaceuticals (NASDAQ:CPIX), a specialty pharmaceutical company, released top-line results from its Phase 2a ASSIST-SSc trial at 4:05 p.m. ET on Friday, October 23, 2026, after the close, so the first full reaction came in early trading on Monday, October 26, 2026. The shares …
Please wait processing your request...